search
Back to results

Collaborative and Stepped Care in Mental Health (COMET) (COMET)

Primary Purpose

Depressive Disorder, Anxiety Disorder, Somatoform Disorder

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
collaborative and stepped care model
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depressive Disorder focused on measuring stepped and collaborative care, cluster-randomized controlled trial, health services research, evidence-based medicine, complex intervention, guideline implementation, collaborative network

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Inclusion criteria are a minimum age of 18, informed consent and one or more of the following positive ICD-10-diagnoses: depressive episode (F32), recurrent depressive disorder (F33), dysthymia (F34.1), agoraphobia (F40.0), social phobia (F40.1), panic disorder (F41.0), generalized anxiety disorder (F41.1), mixed anxiety and depressive disorder (F41.2), somatoform disorders (F45), and/or mental and behavioral disorders due to use of alcohol (F10.1, F.10.2)

Exclusion Criteria:

  • Patients with insufficient knowledge of the German language, an acute psychosis or a health situation that does not allow questionnaire completion or patients already receiving current in- or outpatient psychiatric or psychotherapeutic care are excluded.

Sites / Locations

  • University Medical Center Hamburg

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention Group

Control Group

Arm Description

collaborative and stepped care model for depressive, anxiety, somatoform and/or alcohol abuse disorders within a multiprofessional network

treatment as usual in German health care system

Outcomes

Primary Outcome Measures

change in health-related quality of life
measured with the Short Form Health Survey SF-36 mental health score

Secondary Outcome Measures

change in disorder-specific symptoms: depression
measured on the major depressive module of the Patient Health Questionnaire PHQ: PHQ-9
change in disorder-specific symptoms: panic
measured on the panic module of the Patient Health Questionnaire PHQ: PHQ-panic module
change in disorder-specific symptoms: generalized anxiety
measured on the generalized anxiety module of the Patient Health Questionnaire PHQ: GAD-7
change in disorder-specific symptoms: somatoform syndrome PHQ
measured on the somatoform module of the Patient Health Questionnaire PHQ: PHQ-15
change in disorder-specific symptoms: somatoform syndrome SSD-12
measured on the Somatic Symptom Disorder-B SSD-12
change in disorder-specific symptoms: alcohol abuse disorder
measured on the Alcohol Use Disorders Identification Test: AUDIT
cost effectiveness: direct costs
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). For the monetary valuation of resources, unit costs will be applied.
cost effectiveness: indirect costs
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). Indirect costs will be calculated based on the human capital approach.
cost effectiveness: health effects
quality-adjusted life years (QALYs) will be calculated based on utilities derived from the EQ-5D-5L questionnaire
cost effectiveness: incremental cost-effectiveness
incremental cost-effectiveness ratios (ICER) will be calculated
cost effectiveness: acceptability
Cost-effectiveness acceptability curves (CEAC) will be calculated.

Full Information

First Posted
July 10, 2017
Last Updated
November 2, 2022
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
Center for Health Care Research Hamburg, Hamburg Center for Health Economics
search

1. Study Identification

Unique Protocol Identification Number
NCT03226743
Brief Title
Collaborative and Stepped Care in Mental Health (COMET)
Acronym
COMET
Official Title
Collaborative and Stepped Care in Mental Health by Overcoming Treatment Sector Barriers: A Cluster-randomized Controlled Trial (COMET)
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
July 12, 2018 (Actual)
Primary Completion Date
April 12, 2021 (Actual)
Study Completion Date
October 7, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
Center for Health Care Research Hamburg, Hamburg Center for Health Economics

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aims of COMET are the implementation and evaluation of effectiveness and cost-effectiveness as well as processes of a collaborative and stepped care model for depressive, anxiety, somatoform and/or alcohol abuse disorders within a multiprofessional network in comparison to routine care. In a cluster-randomized controlled effectiveness trial 570 patients will be recruited by 38 general practitioner practices and followed with a prospective survey at four time points. The primary outcome is the change in health-related quality of life from baseline to 6-months follow-up. Secondary outcomes include disorder-specific symptom burden, response, remission, functional quality of life, cost-effectiveness, evaluation of processes and other clinical and psychosocial variables.
Detailed Description
Aims are a) the implementation and outcome evaluation, b) the process evaluation, and c) the analysis of the cost-effectiveness of an innovative collaborative and stepped care model for patients with depressive, anxiety, somatoform and/or alcohol abuse disorders. Its novelty is the integration of these four disorders into one model. This approach is based on a) the high comorbidity between these disorders, b) the fact that they share a common etiological and diag-nostic basis, c) that similar evidence-based treatment options exist for them (e.g., self-help and psychoeducation, psychotherapy, pharmacotherapy), and d) that health care providers need to manage them together very often. The conceptual basis follows the principles of evidence-based medicine with a specific focus on guideline implementation and the principles of patient-centered care including access, coordination and continuity of care, patient information, patient involvement and empowerment. Based on a multi-professional cooperation of health care providers across different care sectors an integrated health care network consisting of general practitioners (GPs), mental health specialists (psychiatrists, psychotherapists) and inpatient facilities will be established. Evidence-based clinical practice guidelines and pathways of care with treatment options of varying intensity form the clinical and procedural basis of the network, including low-intensity treatments and e-mental health technologies. The study is planned as a randomized controlled effectiveness trial of a consecutive sample of patients with depressive and/or anxiety and/or somatoform and/or alcohol abuse disorders drawn from primary care (GP practices) and followed with a prospective survey at four time points. The study is intended to recruit a total of 570 patients from 38 GP practices. A cluster-randomization at the level of participating GP practices divides GPs into the intervention group, where patients are treated within a multi-professional collaborative and stepped care approach (including low-intensity treatments, direct access to mental health specialists, inpatient care etc., COMET), and the control group, where patients receive standard care (treatment as usual, TAU). Data collection is carried out with questionnaires as well as telephone interviews at four time-standardized measurement points within one year (baseline, 3, 6, 12 and 24 months). Additionally, independent research assistants perform standardized diagnostic interviews (CIDI) with patients at baseline to allow an assessment of diagnostic validity. The main research hypothesis is that the COMET model is more effective than TAU. Primary outcome is the change in health-related quality of life measured by the SF-36 mental health score from baseline to 6-months follow-up. Secondary outcomes include symptom burden of depressive, generalized anxiety, panic, somatoform and alcohol abuse syndromes (PHQ-9; GAD-7; PHQ-15; PHQ panic and alcohol abuse syndrome module; SSD-12), disorder-specific response and remission, functional quality of life (EQ-5D-5L), duration of untreated illness, and other clinical and psychosocial variables (outcome evaluation, Work Package 1). Furthermore, direct and indirect costs and the incremental cost-effectiveness ratio will be assessed (economic evaluation, Work Package 2). Finally, feasibility and acceptance of the COMET model as well as of the different treatment components are assessed, including the implementation process (process evaluation, Work Package 3). To this end, semi-structured interviews will be conducted at two measurement points, supplemented by standardized surveys among involved patients and providers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depressive Disorder, Anxiety Disorder, Somatoform Disorder, Alcohol Use Disorder
Keywords
stepped and collaborative care, cluster-randomized controlled trial, health services research, evidence-based medicine, complex intervention, guideline implementation, collaborative network

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
615 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
collaborative and stepped care model for depressive, anxiety, somatoform and/or alcohol abuse disorders within a multiprofessional network
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
treatment as usual in German health care system
Intervention Type
Other
Intervention Name(s)
collaborative and stepped care model
Intervention Description
Including elements: collaborative and stepped care of patients with mental disorders treatment in a multiprofessional network consisting of primary care physicians, psychologists, psychiatrists and inpatient facilities initial training of participating health care providers formalized and standardized screening procedure for early recognition of depressive, anxiety, somatoform and alcohol abuse disorders formalized ICD-diagnostics guideline-oriented treatment recommendations bibliotherapy or internet-based self-help for patient with mild to moderate disorders online referral platform case management for patients with severe disorders systematic and regular monitoring regular quality circles for participating health care providers
Primary Outcome Measure Information:
Title
change in health-related quality of life
Description
measured with the Short Form Health Survey SF-36 mental health score
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Secondary Outcome Measure Information:
Title
change in disorder-specific symptoms: depression
Description
measured on the major depressive module of the Patient Health Questionnaire PHQ: PHQ-9
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
change in disorder-specific symptoms: panic
Description
measured on the panic module of the Patient Health Questionnaire PHQ: PHQ-panic module
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
change in disorder-specific symptoms: generalized anxiety
Description
measured on the generalized anxiety module of the Patient Health Questionnaire PHQ: GAD-7
Time Frame
from baseline to 6 months and 12 months and 24 months after baseline
Title
change in disorder-specific symptoms: somatoform syndrome PHQ
Description
measured on the somatoform module of the Patient Health Questionnaire PHQ: PHQ-15
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
change in disorder-specific symptoms: somatoform syndrome SSD-12
Description
measured on the Somatic Symptom Disorder-B SSD-12
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
change in disorder-specific symptoms: alcohol abuse disorder
Description
measured on the Alcohol Use Disorders Identification Test: AUDIT
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
cost effectiveness: direct costs
Description
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). For the monetary valuation of resources, unit costs will be applied.
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
cost effectiveness: indirect costs
Description
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). Indirect costs will be calculated based on the human capital approach.
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
cost effectiveness: health effects
Description
quality-adjusted life years (QALYs) will be calculated based on utilities derived from the EQ-5D-5L questionnaire
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
cost effectiveness: incremental cost-effectiveness
Description
incremental cost-effectiveness ratios (ICER) will be calculated
Time Frame
from baseline to 6 months and 12 and 24 months after baseline
Title
cost effectiveness: acceptability
Description
Cost-effectiveness acceptability curves (CEAC) will be calculated.
Time Frame
from baseline to 6 months and 12 and 24 months after baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Inclusion criteria are a minimum age of 18, informed consent and one or more of the following positive ICD-10-diagnoses: depressive episode (F32), recurrent depressive disorder (F33), dysthymia (F34.1), agoraphobia (F40.0), social phobia (F40.1), panic disorder (F41.0), generalized anxiety disorder (F41.1), mixed anxiety and depressive disorder (F41.2), somatoform disorders (F45), and/or mental and behavioral disorders due to use of alcohol (F10.1, F.10.2) Exclusion Criteria: Patients with insufficient knowledge of the German language, an acute psychosis or a health situation that does not allow questionnaire completion or patients already receiving current in- or outpatient psychiatric or psychotherapeutic care are excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Härter, Prof. Dr. Dr.
Organizational Affiliation
Center for Psychosocial Medicine, Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Center Hamburg
City
Hamburg
ZIP/Postal Code
20252
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34098913
Citation
Maehder K, Werner S, Weigel A, Lowe B, Heddaeus D, Harter M, von dem Knesebeck O. How do care providers evaluate collaboration? - qualitative process evaluation of a cluster-randomized controlled trial of collaborative and stepped care for patients with mental disorders. BMC Psychiatry. 2021 Jun 8;21(1):296. doi: 10.1186/s12888-021-03274-3.
Results Reference
derived
PubMed Identifier
32896756
Citation
Weigel A, Maehder K, Witt M, Lowe B. Psychotherapists' perspective on the treatment of patients with somatic symptom disorders. J Psychosom Res. 2020 Nov;138:110228. doi: 10.1016/j.jpsychores.2020.110228. Epub 2020 Aug 29.
Results Reference
derived
PubMed Identifier
32023303
Citation
Maehder K, Lowe B, Harter M, Heddaeus D, von dem Knesebeck O, Weigel A. Psychotherapists' perspectives on collaboration and stepped care in outpatient psychotherapy-A qualitative study. PLoS One. 2020 Feb 5;15(2):e0228748. doi: 10.1371/journal.pone.0228748. eCollection 2020.
Results Reference
derived
PubMed Identifier
31767595
Citation
Heddaeus D, Dirmaier J, Brettschneider C, Daubmann A, Grochtdreis T, von dem Knesebeck O, Konig HH, Lowe B, Maehder K, Porzelt S, Rosenkranz M, Schafer I, Scherer M, Schulte B, Wegscheider K, Weigel A, Werner S, Zimmermann T, Harter M. Study protocol for the COMET study: a cluster-randomised, prospective, parallel-group, superiority trial to compare the effectiveness of a collaborative and stepped care model versus treatment as usual in patients with mental disorders in primary care. BMJ Open. 2019 Nov 24;9(11):e032408. doi: 10.1136/bmjopen-2019-032408.
Results Reference
derived
PubMed Identifier
30535053
Citation
Maehder K, Lowe B, Harter M, Heddaeus D, Scherer M, Weigel A. Management of comorbid mental and somatic disorders in stepped care approaches in primary care: a systematic review. Fam Pract. 2019 Jan 25;36(1):38-52. doi: 10.1093/fampra/cmy122.
Results Reference
derived

Learn more about this trial

Collaborative and Stepped Care in Mental Health (COMET)

We'll reach out to this number within 24 hrs